Table 1 Comparison of clinical parameters and lab data between male and female in nephrolithiasis patients
From: Association between low bone mass and the serum RANKL and OPG in patients with nephrolithiasis
Clinical parameters | Total | Male patients | Female patients | p-value |
|---|---|---|---|---|
Median(25th–75th) | Median(25th–75th) | Median(25th–75th) | ||
Age(years) | 47.5 ± 11.94 | 50.19 ± 12.43 | 45.04 ± 11.17 | 0.15 |
BMI(Kg/m2) | 28.94 ± 4.21 | 28.65 ± 4.90 | 29.2 ± 3.56 | 0.67 |
Lab data | ||||
OPG(pmol/l) | 3.5(2.9–4) | 3.4(2.9–4.3) | 3.6(2.8–3.9) | 0.61 |
sRANKL(pmol/l) | 0.2(0.1–0.3) | 0.2(0.1–0.3) | 0.2(0.1–0.3) | 0.85 |
BUN(mg/dl) | 15.2(12.98–17.38) | 15.8(14.15–18.45) | 14(11.8–16.3) | 0.02 |
Creatinie (mg/dl) | 0.9(0.8–1.1) | 1.1(1–1.25) | 0.8(0.8–0.9) | ≤ 0.001 |
Uric acid (mg/dl) | 5.45(4.03–6.3) | 6.3(5.65–7.25) | 4.4(3.3–5.3) | ≤ 0.001 |
Ca(mg/dl) | 9.6(8.9–9.98) | 9.7(8.95–10.05) | 9.5(8.9–9.9) | 0.2 |
P(mg/dl) | 3.4(3.13–4.18) | 3.3(3–4) | 3.6(3.3–4.2) | 0.19 |
Urine volume(ml/24 h) | 1350(900–2237.5) | 1650(950–2237.5) | 1150(825–2250) | 0.39 |
Urine creatinine(mg/24 h) | 1227(949.5–1624) | 1538(1150–1789.5) | 1011(725–1273.5) | 0.003 |
Urine uric acid(mg/24 h) | 593(405–804.5) | 786(436–865.25) | 547(390–760.5) | 0.14 |
Urine calcium (mg/24 h) | 209.5(150–327) | 193.5(152.5–285) | 232(105–340.5) | 0.9 |
Urine phosphorus (mg/24 h) | 741.5(592.5–958) | 832(663.75–1163.5) | 671(484.5–814.5) | 0.04 |
PTH(pg/ml) | 32.9(24.65–42.83) | 36.1(27.1–41.8) | 31.1(20.7–61.4) | 0.5 |
Vitamin D(nmol/l) | 36.8(25.45–61.10) | 40(27.1–56.7) | 31.55(20.5–64.45) | 0.41 |
Urine citrate (mg/24 h) | 493(267–740) | 427(277–674) | 592(225–756.25) | 0.3 |
Na(mEq/l) | 137.4(136.8–138.35) | 137.3(136.75–138) | 137.5(136.8–139) | 0.5 |
eGFR (ml/minute) | 102.48(82.27–119.33) | 101.98(79.14–117.83) | 103.62(82.43–125.85) | 0.71 |
kidney stone disease duration (year) | 3.5(1, 11) | 3.25(1–8.88) | 4.5(1–11.5) | 0.66 |